These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16712415)
1. An interview with Wayne Bowen, Ph.D. Interview by Vicki Glaser. Bowen W Assay Drug Dev Technol; 2006 Apr; 4(2):111-7. PubMed ID: 16712415 [No Abstract] [Full Text] [Related]
3. An interview with Jeffrey Price, M.D., PH.D. Interview by Vicki Glaser. Price J Assay Drug Dev Technol; 2005 Oct; 3(5):467-81. PubMed ID: 16305305 [No Abstract] [Full Text] [Related]
4. Mark A. Goldberg, M.D. is interviewed by Vicki Glaser. Goldberg MA Telemed J E Health; 2009 Jan; 15(1):10-3. PubMed ID: 19199841 [No Abstract] [Full Text] [Related]
5. An interview with Larry Sklar, Ph.D., and Bruce Edwards, Ph.D. Interview by Vicki Glaser. Sklar L; Edwards B Assay Drug Dev Technol; 2010 Aug; 8(4):397-407. PubMed ID: 20804420 [No Abstract] [Full Text] [Related]
6. An interview with David E. Harrison, Ph.D. Interview by Vicki Glaser. Harrison DE Rejuvenation Res; 2007 Sep; 10(3):417-23. PubMed ID: 17822356 [No Abstract] [Full Text] [Related]
7. Interview with Harvey Artsob, Ph.D. Interview by Vicki Glaser. Artsob H Vector Borne Zoonotic Dis; 2008 Oct; 8(5):721-6. PubMed ID: 18837669 [No Abstract] [Full Text] [Related]
9. An interview with Peter J. Hornsby, Ph.D. Interview by Vicki Glaser. Hornsby PJ J Anti Aging Med; 2003; 6(2):77-81. PubMed ID: 14614797 [No Abstract] [Full Text] [Related]
10. An interview with Anne Hermanowski-Vosatka, M.D., Ph.D. Interview by Vicki Glaser. Hermanowski-Vosatka A Assay Drug Dev Technol; 2005 Aug; 3(4):363-6. PubMed ID: 16180990 [No Abstract] [Full Text] [Related]
11. An interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute. Interviewed by Vicki Glaser. Fabbro D Assay Drug Dev Technol; 2004 Apr; 2(2):109-14. PubMed ID: 15165506 [No Abstract] [Full Text] [Related]
12. National Institute on Aging. Interview by Vicki Glaser. Hodes RJ Rejuvenation Res; 2006; 9(3):419-22. PubMed ID: 16859485 [No Abstract] [Full Text] [Related]
14. An interview with Peter J. Coassin. Interview by Vicki Glaser. Coassin PJ Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687 [No Abstract] [Full Text] [Related]
15. An interview with Stephen D. O'Connor, Ph.D. CEO, Nanostream, conducted by Glaser, Vicki. O'Connor SD Assay Drug Dev Technol; 2006 Dec; 4(6):633-6. PubMed ID: 17199501 [No Abstract] [Full Text] [Related]
16. An interview with Erez Raz, Ph.D. Interview by Vicki Glaser. Raz E Zebrafish; 2004; 1(1):9-11. PubMed ID: 18248200 [No Abstract] [Full Text] [Related]
17. An interview with John Postlethwait, Ph.D. Interview by Vicki Glaser. Postlethwait J Zebrafish; 2004; 1(1):3-8. PubMed ID: 18248199 [No Abstract] [Full Text] [Related]
18. An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser. Collins S Assay Drug Dev Technol; 2005 Jun; 3(3):253-60. PubMed ID: 15971987 [No Abstract] [Full Text] [Related]
19. Investigator profile. An interview with Jo-Ann Leong, Ph.D. Interview by Vicki Glaser. Leong JA Zebrafish; 2005; 2(3):165-9. PubMed ID: 18248191 [TBL] [Abstract][Full Text] [Related]
20. Interview with Brian Kennedy, Ph.D. Interview by Vicki Glaser. Kennedy B Rejuvenation Res; 2012 Oct; 15(5):534-7. PubMed ID: 22985122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]